Clinical Trial: Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Effect of Procrit(Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation
Brief Summary: Delayed graft function (DGF) is a major complication following deceased donor renal transplantation. The surgical procedure of harvesting a kidney from a cadaveric donor and implanting the kidney into the recipient inevitably causes some amount of injury. While not always clinically significant, anywhere from 10-50% of transplant patients may develop DGF. Ongoing research in animal models has demonstrated benefit with administration of erythropoietin. The investigators propose to study the effect of Procrit(Epoetin Alfa) on delayed graft function in subjects undergoing kidney transplantation.
Detailed Summary:
Sponsor: West Penn Allegheny Health System
Current Primary Outcome: Decrease in Delayed Graft Function
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: West Penn Allegheny Health System
Dates:
Date Received: January 18, 2007
Date Started: February 2007
Date Completion:
Last Updated: May 25, 2010
Last Verified: May 2010